Toward an epidemiology of refractory migraine: Current knowledge and issues for future research

Headache

Volumn 48, Issue 6, 2008, Pages 791-798

  Lipton, Richard B ^a,b   Bigal, Marcelo E ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Disability; Epidemiology; Refractory migraine

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; DIHYDROERGOTAMINE; DILTIAZEM; DULOXETINE; FLUOXETINE; GABAPENTIN; IBUPROFEN; MAGNESIUM; METOPROLOL; NADOLOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; NUTRACEUTICAL; PAROXETINE; PETASITES HYBRIDUS EXTRACT; PROPRANOLOL; SERTRALINE; TANACETUM PARTHENIUM EXTRACT; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROATE SEMISODIUM; VENLAFAXINE; VERAPAMIL;

DISEASE CLASSIFICATION; DRUG THERAPY; HEADACHE; HUMAN; LIFESTYLE; MEDICAL RESEARCH; MIGRAINE; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; REFRACTORY CHRONIC MIGRAINE; REFRACTORY MIGRAINE; REVIEW; SCORING SYSTEM; TRANSFORMED MIGRAINE; TREATMENT FAILURE;

DISABILITY EVALUATION; HEADACHE DISORDERS; HUMANS; LIFE STYLE; MIGRAINE DISORDERS; PAIN, INTRACTABLE; QUALITY OF LIFE; RESEARCH;

EID: 44849121664     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01131.x     Document Type: Review

References (45)

1. Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 27 : 193 210.
2. Lipton RB, Bigal ME. Ten lessons on the epidemiology of migraine. Headache. 2007 47 (Suppl. 1 S2 9.
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988 8 (Suppl. 7 1 96.
4. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, ed. 2. Cephalalgia. 2004 24 (Suppl. 1 1 15.
5. Schwartz BS, Stewart WF, Simon D, Lipton RB. The epidemiology of tension type headache. JAMA. 1998 279 : 381 383.
6. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.
7. Steiner TJ, Scher AI, Stewart WF, et al. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia. 2003 23 : 519 527.
8. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 68 : 343 349.
9. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998 38 : 497 506.
10. Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999 39 : 190 196.
11. Stewart WF, Ricci JA, Chee E, et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003 290 : 2443 2454.
12. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: Disability and economic costs. Arch Intern Med. 1999 159 : 813 818.
13. Lipton RB, Silberstein SD, Saper JR, Bigal ME, Goadsby PJ. Why headache treatment fails. Neurology. 2003 60 : 1064 1070.
14. Schulman E. Article in this supplement.
15. Scher AI, Stewart WF, Lipton RB. Migraine and headache: A meta-analytic approach. In : Crombie IK, Croft PR, Linton SJ, eds. Epidemiology of Pain. Seattle, WA : IASP Press 1999 : 159 170.
16. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992 267 : 64 69.
17. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology. 1996 47 : 871 875.
18. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26 : 742 746.
19. Bigal ME, Lipton RB. When migraine progresses: Transformed or chronic migraine. Expert Rev Neurother. 2006 6 : 297 306.
20. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology. 2005 65 (12 Suppl. 4 S50 8.
21. Cady R, Farmer K, Beach ME, Tarrasch J. Nurse-based education: An office-based comparative model for education of migraine patients. Headache. 2008 48 : 564 569.
22. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: Measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). Headache. 2005 6 : 429 440.
23. Hamelsky SW, Lipton RB, Stewart WF. An assessment of the burden of migraine using the willingness to pay model. Cephalalgia. 2005 25 : 87 100.
24. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001 56 (6 Suppl. 1 S20 8.
25. Solomon GD. Evolution of the measurement of quality of life in migraine. Neurology. 1997 48 (Suppl. 3 10 15.
26. Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well being of headache patient: Measurement by the medical outcomes study. JAMA. 1989 262 : 907 913.
27. Hurst B, Macclesfield U. Assessing outcomes of treatment for migraine headache using generic and specific measurements. Neurology. 1998 50 (Suppl. 4 180 181.
28. Jhingran P, Osterhaus JT, Miller DW, et al. Development and validation of the migraine-specific quality of life questionnaire. Headache. 1998 38 : 295 302.
29. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache. 1995 35 : 330 337.
30. Gobel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: A nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia. 1994 14 : 97 106.
31. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population: The GEM study. Neurology. 2000 55 : 624 629.
32. Lipton RB, Liberman JN, Kolodner KB, et al. Migraine headache disability and quality of life: A population-based case-control study. Headache. 1999 39 : 365.
33. Campbell JK, Penzien D, Wall EM. Evidence-based guidelines for migraine: behavioral and physical treatments. Available at: http://www.aan.com/ professionals/practice/pdfs/gl0089.pdf.
34. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache. 2007 47 : 355 363.
35. Silberstein SD, Olesen J, Bousser MG, et al. International Headache Society. The international classification of headache disorders, 2nd edn. (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005 25 : 460 5.
36. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26 : 742 746.
37. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004 62 : 788 790.
38. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression (or for chronic daily headaches) - clinical lessons. Headache. 2006 46 (Suppl. 3 S144 6.
39. Mathew NT. Drug-induced headache. Neurol Clin. 1990 8 : 903 912.
40. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: Comparison of strategies. Cephalalgia. 2003 23 : 982 993.
41. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006 1 : 103 107.
42. Compton WM, Stein JB, Robertson EB, Pintello D, Pringle B, Volkow ND. Charting a course for health services research at the national institute on drug abuse. J Subst Abuse Treat. 2005 29 : 167 172.
43. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA. 2002 16 : 337 344.
44. Bigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia. 2004 24 : 483 490.
45. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache. 1996 36 : 14 19.